1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Anemia in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"This had not been analyzed for renal cell carcinomas (RCCs)." | 1.34 | Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. ( Gobe, G; Johnson, DW; Li, J; Vesey, DA, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J | 1 |
Vesey, DA | 1 |
Johnson, DW | 1 |
Gobe, G | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Anemia
Article | Year |
---|---|
Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Anemia; Apoptosis; Carcinoma, Renal Cell; Cell Line, | 2007 |